CERAD Project Centre for the Design and Synthesis of Radioitologically-oriented radiopharmaceuticals (Q84136): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: summary (P836): Reference number_programme:___ SA.48425 (2017/X) _Public service: _art.26 The project consists of the creation of a Centre for the Design and Synthesis of radiopharmaceuticals, ‘CERAD’, ‘CERAD’, the strategic research infrastructure listed in the list of Polish Research Infrastructure Maps.The planned infrastructure will be used both economically and economically.The project will be carried out by a consortium led by the applicant — the Nation...) |
(Created claim: summary (P836): Help programme reference_number: ___ SA.48425 (2017/X) Purpose of public aid:_art. 26 The project concerns the creation of a Centre for Design and Synthesis of Molecularly oriented Radiopharmaceuticals “CERAD” – a strategic research infrastructure listed on the Polish Road Map of Research Infrastructure. The planned infrastructure will be used both economically and economically. The project will be implemented by a consortium headed by the Appli...) |
||||||||||||||
| Property / summary | |||||||||||||||
Help programme reference_number: ___ SA.48425 (2017/X) Purpose of public aid:_art. 26 The project concerns the creation of a Centre for Design and Synthesis of Molecularly oriented Radiopharmaceuticals “CERAD” – a strategic research infrastructure listed on the Polish Road Map of Research Infrastructure. The planned infrastructure will be used both economically and economically. The project will be implemented by a consortium headed by the Applicant – National Centre for Nuclear Research (hereinafter NCBJ) – Consortium Leader and the sole beneficiary of the aid and consortiums – Warsaw University of Warsaw, Institute of Chemistry and Nuclear Technology, Warsaw Medical University, Jagiellonian University Medical College and Medical University in Białystok. The aim of the project is to create a modern research infrastructure in the area of searching for new radiopharmaceuticals for diagnostics and therapy, based on biologically active ligands operating at the cellular and molecular level. The combination of isotope techniques with molecular markers of disease condition will enable early detection of diseases and the implementation of appropriate therapeutic procedures. The project therefore responds to global socio-demographic trends and challenges related to the development of effective methods of cancer diagnosis and therapy. The implementation of the project requires the purchase and construction of fixed assets as well as the use of existing infrastructure elements. The CERAD infrastructure elements for purchase and construction of the project are: 1. Construction of a three-storey building CERAD 2. Cyclotron with particle energy up to 30 MeV. 3. Labs with equipment. Other elements of the proposed CERAD infrastructure are: MARIA nuclear reactor, Świerk IT Center, Preclinical Research Laboratory and POLATOM Research Department equipment. These elements are owned by NCBJ. The rest of infr (English) | |||||||||||||||
| Property / summary: Help programme reference_number: ___ SA.48425 (2017/X) Purpose of public aid:_art. 26 The project concerns the creation of a Centre for Design and Synthesis of Molecularly oriented Radiopharmaceuticals “CERAD” – a strategic research infrastructure listed on the Polish Road Map of Research Infrastructure. The planned infrastructure will be used both economically and economically. The project will be implemented by a consortium headed by the Applicant – National Centre for Nuclear Research (hereinafter NCBJ) – Consortium Leader and the sole beneficiary of the aid and consortiums – Warsaw University of Warsaw, Institute of Chemistry and Nuclear Technology, Warsaw Medical University, Jagiellonian University Medical College and Medical University in Białystok. The aim of the project is to create a modern research infrastructure in the area of searching for new radiopharmaceuticals for diagnostics and therapy, based on biologically active ligands operating at the cellular and molecular level. The combination of isotope techniques with molecular markers of disease condition will enable early detection of diseases and the implementation of appropriate therapeutic procedures. The project therefore responds to global socio-demographic trends and challenges related to the development of effective methods of cancer diagnosis and therapy. The implementation of the project requires the purchase and construction of fixed assets as well as the use of existing infrastructure elements. The CERAD infrastructure elements for purchase and construction of the project are: 1. Construction of a three-storey building CERAD 2. Cyclotron with particle energy up to 30 MeV. 3. Labs with equipment. Other elements of the proposed CERAD infrastructure are: MARIA nuclear reactor, Świerk IT Center, Preclinical Research Laboratory and POLATOM Research Department equipment. These elements are owned by NCBJ. The rest of infr (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: Help programme reference_number: ___ SA.48425 (2017/X) Purpose of public aid:_art. 26 The project concerns the creation of a Centre for Design and Synthesis of Molecularly oriented Radiopharmaceuticals “CERAD” – a strategic research infrastructure listed on the Polish Road Map of Research Infrastructure. The planned infrastructure will be used both economically and economically. The project will be implemented by a consortium headed by the Applicant – National Centre for Nuclear Research (hereinafter NCBJ) – Consortium Leader and the sole beneficiary of the aid and consortiums – Warsaw University of Warsaw, Institute of Chemistry and Nuclear Technology, Warsaw Medical University, Jagiellonian University Medical College and Medical University in Białystok. The aim of the project is to create a modern research infrastructure in the area of searching for new radiopharmaceuticals for diagnostics and therapy, based on biologically active ligands operating at the cellular and molecular level. The combination of isotope techniques with molecular markers of disease condition will enable early detection of diseases and the implementation of appropriate therapeutic procedures. The project therefore responds to global socio-demographic trends and challenges related to the development of effective methods of cancer diagnosis and therapy. The implementation of the project requires the purchase and construction of fixed assets as well as the use of existing infrastructure elements. The CERAD infrastructure elements for purchase and construction of the project are: 1. Construction of a three-storey building CERAD 2. Cyclotron with particle energy up to 30 MeV. 3. Labs with equipment. Other elements of the proposed CERAD infrastructure are: MARIA nuclear reactor, Świerk IT Center, Preclinical Research Laboratory and POLATOM Research Department equipment. These elements are owned by NCBJ. The rest of infr (English) / qualifier | |||||||||||||||
point in time: 14 October 2020
| |||||||||||||||
Revision as of 14:35, 14 October 2020
Project in Poland financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CERAD Project Centre for the Design and Synthesis of Radioitologically-oriented radiopharmaceuticals |
Project in Poland financed by DG Regio |
Statements
73,044,454.96 zloty
0 references
92,201,139.22 zloty
0 references
79.22 percent
0 references
1 August 2017
0 references
31 December 2022
0 references
NARODOWE CENTRUM BADAŃ JĄDROWYCH
0 references
Numer_referencyjny_programu pomocowego: _________ SA.48425 (2017/X) Przeznaczenie_pomocy_publicznej:_art. 26 Projekt dotyczy stworzenia Centrum Projektowania i Syntezy Radiofarmaceutyków Ukierunkowanych Molekularnie „CERAD” – strategicznej infrastruktury badawczej wpisanej na listę Polskiej Mapy Drogowej Infrastruktury Badawczej. Planowana infrastruktura będzie wykorzystywana zarówno niegospodarczo jak i gospodarczo. Projekt będzie realizowany przez konsorcjum na czele z Wnioskodawcą – Narodowym Centrum Badań Jądrowych (dalej NCBJ) – Liderem Konsorcjum i jedynym beneficjentem pomocy oraz konsorcjantami – Uniwersytetem Warszawskim, Instytutem Chemii i Techniki Jądrowej, Warszawskim Uniwersytetem Medycznym, Uniwersytetem Jagiellońskim Collegium Medicum oraz Uniwersytetem Medycznym w Białymstoku. Celem projektu jest stworzenie nowoczesnej infrastruktury badawczej w obszarze poszukiwania nowych radiofarmaceutyków do diagnostyki i terapii, opartych na aktywnych biologicznie ligandach działających na poziomie komórkowym i molekularnym. Połączenie technik izotopowych z molekularnymi markerami stanu chorobowego umożliwi wcześniejsze wykrywanie schorzeń i wdrożenie odpowiednich procedur terapeutycznych. Realizowany projekt stanowi zatem odpowiedź na ogólnoświatowe trendy społeczno-demograficzne i wyzwania związane opracowywaniem skutecznych metod diagnostyki i terapii nowotworów. Realizacja projektu wymaga zakupu i budowy środków trwałych a także wykorzystania aktualnie posiadanych elementów infrastrukturalnych. Elementy infrastruktury CERAD przewidziane do zakupu i budowy w ramach projektu to: 1. Budowa trójkondygnacyjnego budynku CERAD 2. Cyklotron o energii cząstek do 30 MeV. 3. Laboratoria z wyposażeniem. Pozostałymi elementami proponowanej infrastruktury CERAD, są: reaktor jądrowy MARIA, Centrum Informatyczne Świerk, Laboratorium Badań Przedklinicznych oraz wyposażenie Działu Badawczego POLATOM. Elementy te są własnością NCBJ. Reszta infr (Polish)
0 references
Help programme reference_number: ___ SA.48425 (2017/X) Purpose of public aid:_art. 26 The project concerns the creation of a Centre for Design and Synthesis of Molecularly oriented Radiopharmaceuticals “CERAD” – a strategic research infrastructure listed on the Polish Road Map of Research Infrastructure. The planned infrastructure will be used both economically and economically. The project will be implemented by a consortium headed by the Applicant – National Centre for Nuclear Research (hereinafter NCBJ) – Consortium Leader and the sole beneficiary of the aid and consortiums – Warsaw University of Warsaw, Institute of Chemistry and Nuclear Technology, Warsaw Medical University, Jagiellonian University Medical College and Medical University in Białystok. The aim of the project is to create a modern research infrastructure in the area of searching for new radiopharmaceuticals for diagnostics and therapy, based on biologically active ligands operating at the cellular and molecular level. The combination of isotope techniques with molecular markers of disease condition will enable early detection of diseases and the implementation of appropriate therapeutic procedures. The project therefore responds to global socio-demographic trends and challenges related to the development of effective methods of cancer diagnosis and therapy. The implementation of the project requires the purchase and construction of fixed assets as well as the use of existing infrastructure elements. The CERAD infrastructure elements for purchase and construction of the project are: 1. Construction of a three-storey building CERAD 2. Cyclotron with particle energy up to 30 MeV. 3. Labs with equipment. Other elements of the proposed CERAD infrastructure are: MARIA nuclear reactor, Świerk IT Center, Preclinical Research Laboratory and POLATOM Research Department equipment. These elements are owned by NCBJ. The rest of infr (English)
14 October 2020
0 references
Identifiers
POIR.04.02.00-14-A001/16
0 references